IBDEI2BJ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39328,2)
 ;;=^5005826
 ;;^UTILITY(U,$J,358.3,39329,0)
 ;;=H40.2221^^153^1921^19
 ;;^UTILITY(U,$J,358.3,39329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39329,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Left Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,39329,1,4,0)
 ;;=4^H40.2221
 ;;^UTILITY(U,$J,358.3,39329,2)
 ;;=^5005828
 ;;^UTILITY(U,$J,358.3,39330,0)
 ;;=H40.2222^^153^1921^20
 ;;^UTILITY(U,$J,358.3,39330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39330,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Left Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,39330,1,4,0)
 ;;=4^H40.2222
 ;;^UTILITY(U,$J,358.3,39330,2)
 ;;=^5005829
 ;;^UTILITY(U,$J,358.3,39331,0)
 ;;=H40.2223^^153^1921^21
 ;;^UTILITY(U,$J,358.3,39331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39331,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Left Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,39331,1,4,0)
 ;;=4^H40.2223
 ;;^UTILITY(U,$J,358.3,39331,2)
 ;;=^5133501
 ;;^UTILITY(U,$J,358.3,39332,0)
 ;;=H40.2224^^153^1921^18
 ;;^UTILITY(U,$J,358.3,39332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39332,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Left Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,39332,1,4,0)
 ;;=4^H40.2224
 ;;^UTILITY(U,$J,358.3,39332,2)
 ;;=^5005830
 ;;^UTILITY(U,$J,358.3,39333,0)
 ;;=H40.2231^^153^1921^15
 ;;^UTILITY(U,$J,358.3,39333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39333,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Mild Stage
 ;;^UTILITY(U,$J,358.3,39333,1,4,0)
 ;;=4^H40.2231
 ;;^UTILITY(U,$J,358.3,39333,2)
 ;;=^5005832
 ;;^UTILITY(U,$J,358.3,39334,0)
 ;;=H40.2232^^153^1921^16
 ;;^UTILITY(U,$J,358.3,39334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39334,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Moderate Stage
 ;;^UTILITY(U,$J,358.3,39334,1,4,0)
 ;;=4^H40.2232
 ;;^UTILITY(U,$J,358.3,39334,2)
 ;;=^5005833
 ;;^UTILITY(U,$J,358.3,39335,0)
 ;;=H40.2233^^153^1921^17
 ;;^UTILITY(U,$J,358.3,39335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39335,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Severe Stage
 ;;^UTILITY(U,$J,358.3,39335,1,4,0)
 ;;=4^H40.2233
 ;;^UTILITY(U,$J,358.3,39335,2)
 ;;=^5005834
 ;;^UTILITY(U,$J,358.3,39336,0)
 ;;=H40.2234^^153^1921^14
 ;;^UTILITY(U,$J,358.3,39336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39336,1,3,0)
 ;;=3^Chr Angle-Closure Glaucoma,Bilateral,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,39336,1,4,0)
 ;;=4^H40.2234
 ;;^UTILITY(U,$J,358.3,39336,2)
 ;;=^5005835
 ;;^UTILITY(U,$J,358.3,39337,0)
 ;;=H40.241^^153^1921^115
 ;;^UTILITY(U,$J,358.3,39337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39337,1,3,0)
 ;;=3^Residual Stage Angle-Closure Glaucoma,Right Eye
 ;;^UTILITY(U,$J,358.3,39337,1,4,0)
 ;;=4^H40.241
 ;;^UTILITY(U,$J,358.3,39337,2)
 ;;=^5005843
 ;;^UTILITY(U,$J,358.3,39338,0)
 ;;=H40.242^^153^1921^114
 ;;^UTILITY(U,$J,358.3,39338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39338,1,3,0)
 ;;=3^Residual Stage Angle-Closure Glaucoma,Left Eye
 ;;^UTILITY(U,$J,358.3,39338,1,4,0)
 ;;=4^H40.242
 ;;^UTILITY(U,$J,358.3,39338,2)
 ;;=^5005844
 ;;^UTILITY(U,$J,358.3,39339,0)
 ;;=H40.61X0^^153^1921^43
 ;;^UTILITY(U,$J,358.3,39339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39339,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,39339,1,4,0)
 ;;=4^H40.61X0
 ;;^UTILITY(U,$J,358.3,39339,2)
 ;;=^5005906
 ;;^UTILITY(U,$J,358.3,39340,0)
 ;;=H40.61X2^^153^1921^41
 ;;^UTILITY(U,$J,358.3,39340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39340,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,39340,1,4,0)
 ;;=4^H40.61X2
